A Word from the President
Christine Peschken
Welcome to our new CaNIOS website!  It is our goal to continue providing the best information to our partners, especially consumers with lupus, on our research activities and, most importantly, on our results and the impact these will have for Canadians and others who live with lupus.

My name is Christine Peschken, and I am a rheumatologist and researcher at the University of Manitoba Arthritis Centre in Winnipeg Manitoba. I finished my clinical rheumatology training in Winnipeg, and completed my research training at McGill University in Montreal, the University of British Columbia in Vancouver, and the Manitoba Centre for Health Policy in Winnipeg. I have been interested in lupus research ever since the beginning of my research training, and continue to be fascinated and challenged by this complex and heterogeneous disease. My own major research interest is in health disparities and vulnerable populations with lupus. Why do some people with lupus do so well, and others much less well? Why is lupus more common among women, ethnic minorities and the poor? These are but a few of the questions that interest me, and that CaNIOS can help to answer.
I am both honored and somewhat daunted to have been chosen as president of CaNIOS at the September annual investigators’ meeting in Vancouver. CaNIOS, as a collegial group of researchers and clinicians with an interest in lupus that spans the country, has a unique opportunity that is unmatched anywhere to perform some really innovative and collaborative research. The diversity of knowledge and interests amongst group members, along with the collaborative nature of the group opens up a wealth of possibilities. This also presents a few challenges, particularly in view of the continued financial restraints that we, along with other research organizations, continue to face. We were all excited to see several new young and enthusiastic members join the group at the fall AGM in Vancouver. Revitalizing our National Lupus Registry was high on our list of priorities for the coming year, and we hope to strengthen our ties with Lupus Canada, the provincial affiliates, and our patients themselves. Working together offers the best chances of developing important research programs and improving outcomes for persons living with lupus in Canada. I look forward to working with everyone this year.
I wish everyone all the best for the coming year
Christine Peschken MD MSc FRCPC
President, Canadian Network for Improved Outcomes in SLE